Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vasa Denticity's Days Sales Outstanding for the
six
months ended in Mar. 2026 was 18.63.
Vasa Denticity's Days Inventory for the
six
months ended in Mar. 2026 was 133.36.
Vasa Denticity's Days Payable for the
six
months ended in Mar. 2026 was 22.02.
Therefore, Vasa Denticity's Cash Conversion Cycle (CCC) for the
six
months ended in Mar. 2026 was 129.97.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Vasa Denticity Cash Conversion Cycle Related Terms
Vasa Denticity Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Vasa Denticity's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:DENTALKART vs MCK, COR, CAH: Cash Conversion Cycle Comparison
For the Medical Distribution subindustry, Vasa Denticity's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vasa Denticity Cash Conversion Cycle vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vasa Denticity's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Vasa Denticity's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Vasa Denticity's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vasa Denticity (NSE:DENTALKART) has a Cash Conversion Cycle of 129.97 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Vasa Denticity and its competitors.
Is Vasa Denticity's Cash Conversion Cycle too high?
Vasa Denticity's current Cash Conversion Cycle is 129.97. The Medical Distribution industry median Cash Conversion Cycle is 52.15. Vasa Denticity's value of 129.97 is 149.2% above this industry median. Overall, Vasa Denticity has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vasa Denticity's Cash Conversion Cycle compare to MCK and COR?
Vasa Denticity's Cash Conversion Cycle of 129.97 can be compared against companies in the Medical Distribution industry. The industry median Cash Conversion Cycle is 52.15. Vasa Denticity's value of 129.97 is 149.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Distribution company?
The median Cash Conversion Cycle among Medical Distribution companies is 52.15, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vasa Denticity's current Cash Conversion Cycle of 129.97 is 149.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Vasa Denticity and its competitors. For the Medical Distribution industry, the median Cash Conversion Cycle is 52.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vasa Denticity's current Cash Conversion Cycle is 129.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasa Denticity stock overvalued right now?
Based on GuruFocus' analysis, Vasa Denticity (NSE:DENTALKART) is currently considered Possible Value Trap. The stock's GF Value™ is ₹877.39, compared to a current price of ₹413.05 — trading 52.9% below its estimated fair value. The current Cash Conversion Cycle is 129.97 and 149.2% above the Medical Distribution industry median of 52.15. Vasa Denticity's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Vasa Denticity (NSE:DENTALKART), the current Cash Conversion Cycle is 129.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vasa Denticity (NSE:DENTALKART) Overvalued in 2026?
Based on GuruFocus' analysis, Vasa Denticity stock appears to be undervalued.
The current stock price of ₹413.05 is trading 52.9% below its estimated GF Value™ of ₹877.39.
GuruFocus considers Vasa Denticity to be Possible Value Trap.
Key valuation signals for NSE:DENTALKART:
Cash Conversion Cycle: 129.97
GF Value™: ₹877.39 vs. price of ₹413.05 (52.9% below fair value)
Industry Position: 149.2% above the Medical Distribution median
No single metric tells the full story. See the NSE:DENTALKART stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vasa Denticity Ltd is engaged in marketing and distributing a comprehensive portfolio of dental products, including consumables, instruments, equipment, and accessories for diagnosing, treating, and preventing dental conditions, as well as improving the aesthetics of the human smile through the online portal Dentalkart.com. The company's products include instruments, disinfectant tools, sterilizing equipment, impression materials, temporary materials for tooth filling, and others.
80GF Score
Get the complete analysis for NSE:DENTALKART
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DENTALKART has been successfully added to your 
